Drug intelligence / Profile preview

PSMA-12-IRDye800CW

Development stage
Preclinical
Lead developer
Technical University of Munich
Modality
Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Intravenous
01

Overview

PSMA-12-IRDye800CW is a targeted near-infrared (NIR) fluorescent imaging agent designed for the intraoperative visualization of prostate cancer. It consists of a small-molecule ligand, PSMA-12, which specifically binds to the prostate-specific membrane antigen (PSMA), conjugated to the fluorophore IRDye800CW. While IRDye800CW is traditionally used for NIR-I imaging, this probe leverages its extended emission tail in the NIR-II window (beyond 1000 nm) to provide superior image contrast, deeper tissue penetration, and reduced autofluorescence. The agent is primarily intended for real-time surgical navigation and histopathological tumor margin mapping, helping surgeons distinguish between malignant and healthy tissue during radical prostatectomy or other oncological procedures.

Other names
PSMA-targeted NIR-II fluorescent probe
02

Targets

PSMA (Prostate-specific membrane antigen)

Beyond the preview

Go deeper on PSMA-12-IRDye800CW.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PSMA-12-IRDye800CW.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call